Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Mood Disorders | Research

Patient-reported gastrointestinal symptoms in patients with peritoneal dialysis: the prevalence, influence factors and association with quality of life

Authors: Chunyan Yi, Xin Wang, Hongjian Ye, Jianxiong Lin, Xiao Yang

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

The aims of this study were to investigate the prevalence and the influence factors of gastrointestinal symptoms, and its association with the quality of life (QOL) in peritoneal dialysis (PD) patients.

Methods

Continuous ambulatory PD patients (CAPD) who followed up in our PD center between March 2016 and December 2017 were enrolled in this cross-sectional study. Gastrointestinal symptom rating scale (GSRS) was used to evaluate gastrointestinal symptoms. The related clinical data were also collected. Multiple linear regression analysis was test for the influence factors associated with score of GSRS and QOL.

Results

This study included 471 CAPD patients. The mean age was 48.5±13.9 years, 53.9% were male and 15.1% with diabetic nephropathy. The median duration of PD was 37.3 (17.5~66.5) months. The median score of GSRS was 1.2(1.1~1.3) scores. Totally 82.2% (n=387) CAPD patients had at least one gastrointestinal symptom. Higher glycosylated hemoglobin, higher score of depression, lower diastolic blood pressure, urine output, score of instrumental activities of daily living scale and more amount of pills per day were independently associated with higher score of GSRS (all P<0.05). Score of dyspepsia and eating dysfunction were independently associated with worse score of QOL and physical health (all P<0.05).

Conclusions

Gastrointestinal symptoms were common but not serious in CAPD patients. Glycemic control, depression, blood pressure, urine output, activity of daily life and amount of pills were all associated with gastrointestinal symptoms. Moreover, gastrointestinal symptoms were correlated with QOL of PD patients.
Literature
1.
go back to reference Kosmadakis G, Albaret J, Da Costa CE, Somda F, Aguilera D. Constipation in Peritoneal Dialysis Patients. Peritoneal Dialysis Int. 2019;39(5):399–404.CrossRef Kosmadakis G, Albaret J, Da Costa CE, Somda F, Aguilera D. Constipation in Peritoneal Dialysis Patients. Peritoneal Dialysis Int. 2019;39(5):399–404.CrossRef
2.
go back to reference Salamon K, Woods J, Paul E, Huggins C. Peritoneal dialysis patients have higher prevalence of gastrointestinal symptoms than hemodialysis patients. J Renal Nutr. 2013;23(2):114–8.CrossRef Salamon K, Woods J, Paul E, Huggins C. Peritoneal dialysis patients have higher prevalence of gastrointestinal symptoms than hemodialysis patients. J Renal Nutr. 2013;23(2):114–8.CrossRef
3.
go back to reference Kosmadakis G, Albaret J, da Costa CE, Somda F, Aguilera D. Gastrointestinal Disorders in Peritoneal Dialysis Patients. Am J Nephrol. 2018;48(5):319–25.CrossRef Kosmadakis G, Albaret J, da Costa CE, Somda F, Aguilera D. Gastrointestinal Disorders in Peritoneal Dialysis Patients. Am J Nephrol. 2018;48(5):319–25.CrossRef
4.
go back to reference Strid H, Simren M, Johansson AC, Svedlund J, Samuelsson O, Bjornsson ES. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrology Dialysis Transpl. 2002;17(8):1434–9.CrossRef Strid H, Simren M, Johansson AC, Svedlund J, Samuelsson O, Bjornsson ES. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrology Dialysis Transpl. 2002;17(8):1434–9.CrossRef
5.
go back to reference Dong R, Guo ZY. Gastrointestinal symptoms in patients undergoing peritoneal dialysis: multivariate analysis of correlated factors. World J Gastroenterol. 2010;16(22):2812–7.CrossRef Dong R, Guo ZY. Gastrointestinal symptoms in patients undergoing peritoneal dialysis: multivariate analysis of correlated factors. World J Gastroenterol. 2010;16(22):2812–7.CrossRef
6.
go back to reference Zuvela J, Trimingham C, Le Leu R, Faull R, Clayton P, Jesudason S, et al. Gastrointestinal symptoms in patients receiving dialysis: A systematic review. Nephrology. 2018;23(8):718–27.CrossRef Zuvela J, Trimingham C, Le Leu R, Faull R, Clayton P, Jesudason S, et al. Gastrointestinal symptoms in patients receiving dialysis: A systematic review. Nephrology. 2018;23(8):718–27.CrossRef
7.
go back to reference Strid H, Simren M, Stotzer PO, Abrahamsson H, Bjornsson ES. Delay in gastric emptying in patients with chronic renal failure. Scand J Gastroenterol. 2004;39(6):516–20.CrossRef Strid H, Simren M, Stotzer PO, Abrahamsson H, Bjornsson ES. Delay in gastric emptying in patients with chronic renal failure. Scand J Gastroenterol. 2004;39(6):516–20.CrossRef
8.
go back to reference Schoonjans R, Van Vlem B, Vandamme W, Van Vlierberghe H, Van Heddeghem N, Van Biesen W, et al. Gastric emptying of solids in cirrhotic and peritoneal dialysis patients: influence of peritoneal volume load. Eur J Gastroenterology Hepatol. 2002;14(4):395–8.CrossRef Schoonjans R, Van Vlem B, Vandamme W, Van Vlierberghe H, Van Heddeghem N, Van Biesen W, et al. Gastric emptying of solids in cirrhotic and peritoneal dialysis patients: influence of peritoneal volume load. Eur J Gastroenterology Hepatol. 2002;14(4):395–8.CrossRef
9.
go back to reference Kim DJ, Kang WH, Kim HY, Lee BH, Kim B, Lee SK, et al. The effect of dialysate dwell on gastric emptying time in patients on continuous ambulatory peritoneal dialysis. Peritoneal Dialysis Int. 1999;19(Suppl 2):S176–8.CrossRef Kim DJ, Kang WH, Kim HY, Lee BH, Kim B, Lee SK, et al. The effect of dialysate dwell on gastric emptying time in patients on continuous ambulatory peritoneal dialysis. Peritoneal Dialysis Int. 1999;19(Suppl 2):S176–8.CrossRef
10.
go back to reference Van V, Schoonjans RS, Struijk DG, Verbanck JJ, Vanholder RC, Van B, et al. Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Peritoneal Dialysis Int. 2002;22(1):32–8.CrossRef Van V, Schoonjans RS, Struijk DG, Verbanck JJ, Vanholder RC, Van B, et al. Influence of dialysate on gastric emptying time in peritoneal dialysis patients. Peritoneal Dialysis Int. 2002;22(1):32–8.CrossRef
11.
go back to reference Kim MJ, Kwon KH, Lee SW. Gastroesophageal reflux disease in CAPD patients. Adv Peritoneal Dialysis Conference Peritoneal Dialysis. 1998;14:98–101. Kim MJ, Kwon KH, Lee SW. Gastroesophageal reflux disease in CAPD patients. Adv Peritoneal Dialysis Conference Peritoneal Dialysis. 1998;14:98–101.
12.
go back to reference Hylander BI, Dalton CB, Castell DO, Burkart J, Rossner S. Effect of intraperitoneal fluid volume changes on esophageal pressures: studies in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1991;17(3):307–10.CrossRef Hylander BI, Dalton CB, Castell DO, Burkart J, Rossner S. Effect of intraperitoneal fluid volume changes on esophageal pressures: studies in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1991;17(3):307–10.CrossRef
13.
go back to reference Duncanson E, Chur-Hansen A, Jesudason S. Psychosocial consequences of gastrointestinal symptoms and dietary changes in people receiving automated peritoneal dialysis. J Renal Care. 2019;45(1):41–50.CrossRef Duncanson E, Chur-Hansen A, Jesudason S. Psychosocial consequences of gastrointestinal symptoms and dietary changes in people receiving automated peritoneal dialysis. J Renal Care. 2019;45(1):41–50.CrossRef
14.
go back to reference Zhang J, Huang C, Li Y, Chen J, Shen F, Yao Q, et al. Health-related quality of life in dialysis patients with constipation: a cross-sectional study. Patient Preference Adherence. 2013;7:589–94.PubMedPubMedCentral Zhang J, Huang C, Li Y, Chen J, Shen F, Yao Q, et al. Health-related quality of life in dialysis patients with constipation: a cross-sectional study. Patient Preference Adherence. 2013;7:589–94.PubMedPubMedCentral
15.
go back to reference Svedlund J, Sjodin I, Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Digestive diseases and sciences. 1988;33(2):129–34.CrossRef Svedlund J, Sjodin I, Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Digestive diseases and sciences. 1988;33(2):129–34.CrossRef
16.
go back to reference Svedlund J, Sullivan M, Liedman B, Lundell L. Long term consequences of gastrectomy for patient’s quality of life: the impact of reconstructive techniques. Am J Gastroenterology. 1999;94(2):438–45.CrossRef Svedlund J, Sullivan M, Liedman B, Lundell L. Long term consequences of gastrectomy for patient’s quality of life: the impact of reconstructive techniques. Am J Gastroenterology. 1999;94(2):438–45.CrossRef
17.
go back to reference Mahoney FI, Barthel DW. Functional Evaluation: The Barthel Index. Maryland State Med J. 1965;14:61–5. Mahoney FI, Barthel DW. Functional Evaluation: The Barthel Index. Maryland State Med J. 1965;14:61–5.
18.
go back to reference Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.CrossRef Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.CrossRef
19.
go back to reference Wang Z, Yuan CM, Huang J, Li ZZ, Chen J, Zhang HY, et al. Reliability and validity of the Chinese version of Beck Depression Inventory-II among depression patients. Chinese Mental Health J. 2011;25(6):476–9. Wang Z, Yuan CM, Huang J, Li ZZ, Chen J, Zhang HY, et al. Reliability and validity of the Chinese version of Beck Depression Inventory-II among depression patients. Chinese Mental Health J. 2011;25(6):476–9.
20.
go back to reference McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care. 1993;31(3):247–63.CrossRef McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care. 1993;31(3):247–63.CrossRef
21.
go back to reference Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016;4:2050312116671725.CrossRef Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016;4:2050312116671725.CrossRef
22.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRef
23.
go back to reference Schvarcz E, Palmer M, Ingberg CM, Aman J, Berne C. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabetic Med. 1996;13(5):478–81.CrossRef Schvarcz E, Palmer M, Ingberg CM, Aman J, Berne C. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabetic Med. 1996;13(5):478–81.CrossRef
24.
go back to reference Kim JH, Park HS, Ko SY, Hong SN, Sung IK, Shim CS, et al. Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes. World J Gastroenterol. 2010;16(14):1782–7.CrossRef Kim JH, Park HS, Ko SY, Hong SN, Sung IK, Shim CS, et al. Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes. World J Gastroenterol. 2010;16(14):1782–7.CrossRef
25.
go back to reference Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Int Med. 2001;161(16):1989–96.CrossRef Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Int Med. 2001;161(16):1989–96.CrossRef
26.
go back to reference Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97(3):604–11.CrossRef Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol. 2002;97(3):604–11.CrossRef
27.
go back to reference Chong VH, Tan J. Prevalence of gastrointestinal and psychosomatic symptoms among Asian patients undergoing regular hemodialysis. Nephrology. 2013;18(2):97–103.CrossRef Chong VH, Tan J. Prevalence of gastrointestinal and psychosomatic symptoms among Asian patients undergoing regular hemodialysis. Nephrology. 2013;18(2):97–103.CrossRef
28.
go back to reference Kahvecioglu S, Akdag I, Kiyici M, Gullulu M, Yavuz M, Ersoy A, et al. High prevalence of irritable bowel syndrome and upper gastrointestinal symptoms in patients with chronic renal failure. J Nephrol. 2005;18(1):61–6.PubMed Kahvecioglu S, Akdag I, Kiyici M, Gullulu M, Yavuz M, Ersoy A, et al. High prevalence of irritable bowel syndrome and upper gastrointestinal symptoms in patients with chronic renal failure. J Nephrol. 2005;18(1):61–6.PubMed
Metadata
Title
Patient-reported gastrointestinal symptoms in patients with peritoneal dialysis: the prevalence, influence factors and association with quality of life
Authors
Chunyan Yi
Xin Wang
Hongjian Ye
Jianxiong Lin
Xiao Yang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-02723-9

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine